MALARONE TABLETS FOR ADULTS

Kraj: Izrael

Język: angielski

Źródło: Ministry of Health

Kup teraz

Składnik aktywny:

ATOVAQUONE; PROGUANIL HYDROCHLORIDE

Dostępny od:

GLAXO SMITH KLINE (ISRAEL) LTD

Kod ATC:

P01BB51

Forma farmaceutyczna:

FILM COATED TABLETS

Skład:

ATOVAQUONE 250 MG; PROGUANIL HYDROCHLORIDE 100 MG

Droga podania:

PER OS

Typ recepty:

Required

Wyprodukowano przez:

GLAXO WELLCOME SA, SPAIN

Grupa terapeutyczna:

PROGUANIL, COMBINATIONS

Dziedzina terapeutyczna:

PROGUANIL, COMBINATIONS

Wskazania:

Prevention of malaria: For the prophylaxis of P.falciparum malaria, including in areas where chloroquine resistance has been reported. Treatment of malaria: For the treatment of acute, uncomplicated P.flaciparum malaria. Malarone has been shown to be effective in regions where the drugs chloroquine, halofantrine, mefloquine, and amodiaquine may have unacceptable failure rates, presumably due to drug resistance.

Data autoryzacji:

2023-05-31

Ulotka dla pacjenta

                                [לוגו מדינת ישראל] [http://www.gov.il/]
[http://www.gov.il/] [לוגו משרד הבריאות] [לוגו משרד
הבריאות] [*5400]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
[http://www.health.gov.il/PniyotHazibur/Pages/CallCenter.aspx]
הציבור הרחב עסקים ומוסדות עובדים
בבריאות חפש מידע
תפריט	*
[סגירה]
סגור	*
דף הבית [http://www.health.gov.il/]	*
אודות	*
אודות המשרד
[http://www.health.gov.il/About/Pages/about_us.aspx]	*
תוכנית עבודה
[http://www.health.gov.il/About/Pages/Agenda.aspx]	*
תקציב המשרד
[http://www.health.gov.il/About/Pages/budget.aspx]	*
תרשים מבנה ארגוני
[http://www.health.gov.il/About/Pages/OrganizationalStructureDiagram.aspx]	*
בעלי תפקידים
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx]	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/About/Phonebook/Pages/PhoneBook.aspx?tab=3]	*
אמנת שירות
[http://www.health.gov.il/About/sla/Pages/default.aspx]	*
אותות ופרסים
[http://www.health.gov.il/About/Awards/Pages/mifal.aspx]	*
פרוייקטים תשתיתיים
[http://www.health.gov.il/About/projects/shared_medical_info/Pages/default.aspx]	*
דרושים
[http://www.health.gov.il/About/Careers/Pages/default.aspx]	*
מנכ"לי משרד הבריאות לדורותיהם
[http://www.health.gov.il/About/Pages/GeneralManegerHistory.aspx]	*
יחידות המשרד	*
יחידות המשרד
[http://www.health.gov.il/UnitsOffice/Pages/UnitsList.aspx]	*
לשכות הבריאות
[http://www.health.gov.il/UnitsOffice/LB/Pages/default.aspx]	*
וועדות ומועצות
[http://www.health.gov.il/Services/Committee/Pages/CommitteeList.aspx]	*
נושאים	*
בריאות הנפש
[http://www.health.gov.il/Subjects/mental_health/Pages/default.aspx]	*
בריאות הסביבה
[http://www.health.gov.il/Subjects/Environmental_Health/
                                
                                Przeczytaj cały dokument
                                
                            

Charakterystyka produktu

                                1
1.
NAME OF THE MEDICINAL PRODUCT
MALARONE TABLETS FOR ADULTS
MALARONE PAEDIATRIC TABLETS
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each Malarone tablet for adults contains 250 mg atovaquone and 100 mg
proguanil hydrochloride.
Each Malarone
_ _
paediatric tablets contains 62.5 mg atovaquone and 25 mg proguanil
hydrochloride.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Film coated tablet.
Malarone tablets for adults – Round, biconvex, pink tablets engraved
‘GX CM3’ on one side.
Malarone
_ _
paediatric tablets – Round, biconvex, pink tablets engraved ‘GX
CG7’ on one side.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
PREVENTION OF MALARIA
Malarone is indicated for the prophylaxis of
_Plasmodium falciparum_
malaria, including in areas where
chloroquine resistance has been reported.
TREATMENT OF MALARIA
Malarone is indicated for the treatment of acute, uncomplicated
_P. falciparum_
malaria. Malarone has
been shown to be effective in regions where the drugs chloroquine,
halofantrine, mefloquine, and
amodiaquine may have unacceptable failure rates, presumably due to
drug resistance.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The daily dose should be taken at the same time each day with food or
a milky drink. In the event of
vomiting within 1 hour after dosing, a repeat dose should be taken.
Malarone Paediatric Tablets:
Malarone may be crushed and mixed with condensed milk just prior to
administration to patients who
may have difficulty swallowing tablets.
Malarone Tablets for adults:
There is no data regarding crush/divide/chew
PREVENTION OF MALARIA
2
Start prophylactic treatment with Malarone 1 or 2 days before entering
a malaria-endemic area and
continue daily during the stay and for 7 days after return.
Adults:
One
tablet
of
Malarone
Tablets
For
Adults
(
250 mg
atovaquone/100 mg
proguanil
hydrochloride) per day.
Paediatric Patients: The dosage for prevention of malaria in
paediatric patients is based upon body
weight (Table 1).
TABLE 1. DOSAGE FOR PREVENTION OF MALARI
                                
                                Przeczytaj cały dokument
                                
                            

Dokumenty w innych językach

Ulotka dla pacjenta Ulotka dla pacjenta arabski 11-07-2021
Ulotka dla pacjenta Ulotka dla pacjenta hebrajski 11-07-2021